Risk for Incident Renal Dialysis in a Managed Care Population

American Journal of Kidney Diseases

Volumn 48, Issue 2, 2006, Pages 205-211

  Roblin, Douglas W ^a   Khoury, Allan ^a   Pisanelli, Wendy ^a   Dahar, Wendy ^a   Roth, Mark ^a  

^a KAISER PERMANENTE   (United States)

Author keywords

hypertension; managed care; Renal dialysis

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MANAGED CARE ORGANIZATION; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; POPULATION RISK; PROPORTIONAL HAZARDS MODEL; RANDOMIZATION; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; SEX RATIO; SMOKING; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TOBACCO; UNITED STATES; URBAN AREA;

ADOLESCENT; ADULT; AGED; BLOOD PRESSURE; COHORT STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; URBAN POPULATION;

EID: 33745939391     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2006.04.082     Document Type: Article

References (32)

1. United States Renal Dialysis System: Incidence and Prevalence of ESRD. Available at: //www.usrds.org/slides.htm. Accessed September 9, 2004.
2. United States Renal Dialysis System: Economic Costs of ESRD. Available at: //www.usrds.org/slides.htm. Accessed September 9, 2004.
3. Coresh J., Astor B.C., Greene T., Eknoyan G., and Levey A.S. Prevalence of chronic kidney disease and decreased kidney function in the adult US population. Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41 (2003) 1-12
4. Perneger T.V., Whelton K.P., and Klag M.J. History of hypertension in patients treated for end-stage renal disease. J Hypertens 15 (1997) 451-456
5. Bakris G.L., Weir M.R., Shanifar S., et al. Effects of blood pressure level on progression of diabetic nephropathy. Results from the RENAAL Study. Arch Intern Med 163 (2003) 1555-1565
6. Brancati F.L., Whelton P.K., Randall B.L., Neaton J.D., Stamler J., and Klag M.J. Risk of end-stage renal disease in diabetes mellitus. A prospective cohort study of men screened for MRFIT. JAMA 278 (1997) 2069-2074
7. Klag M.J., Whelton P.K., Randall B.L., et al. Blood pressure and end-stage renal disease in men. N Engl J Med 334 (1996) 13-18
8. Perry H.M., Miller P., Rossiter Fornoff J., et al. Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension 25 (1995) 587-594
9. Haroun M.K., Jaar B.G., Hoffman S.C., Comstock G.W., Klag M.J., and Coresh J. Risk factors for chronic kidney disease. A prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol 14 (2003) 2934-2941
10. Perneger T.V., Brancati F.L., Whelton P.K., and Klag M.J. End-stage renal disease attributable to diabetes mellitus. Ann Intern Med 121 (1994) 912-918
11. Bleyer A.J., Chen R., D'Agostino R.B., and Appel R.G. Clinical correlates of hypertensive end-stage renal disease. Am J Kidney Dis 31 (1998) 28-34
12. Muntner P., Coresh J., Klag M.J., Whelton P.K., and Perneger T.V. History of myocardial infarction and stroke among incident end-stage renal disease cases and population-based controls. An analysis of shared risk factors. Am J Kidney Dis 40 (2002) 323-330
13. Bleyer A.J., Shemanski L.R., Burke G.L., Hansen K.J., and Appel R.G. Tobacco, hypertension, and vascular disease. Risk factors for renal function decline in an older population. Kidney Int 57 (2000) 2072-2079
14. Chen J., Muntner P., Hamm L.L., et al. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 140 (2004) 167-174
15. Coresh J., Wei G.L., McQuillan G., et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States. Findings from the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 161 (2001) 1207-1216
16. Edwards M.S., Hansen K.J., Craven T.E., et al. Relationships between renovascular disease, blood pressure, and renal function in the elderly. A population-based study. Am J Kidney Dis 41 (2003) 990-996
17. Ejerblad E., Fored C.M., Lindblad P., et al. Association between smoking and chronic renal failure in a nationwide population-based case-control study. J Am Soc Nephrol 15 (2004) 2178-2185
18. Fox C.S., Larson M.G., Leip E.P., Culleton B., Wilson W.F., and Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA 291 (2004) 844-850
19. Hunsicker L.G., Adler S., Caggiula A., et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 51 (1997) 1908-1919
20. Klein R., Klein B.E.K., Moss S.E., Cruickshanks K.J., and Brazy P.C. The 10-year incidence of renal insufficiency in people with type 1 diabetes. Diabetes Care 22 (1999) 743-751
21. Perneger T.V., Nieto F.J., Whelton P.K., Klag M.J., Comstock G.W., and Szklo M. A prospective study of blood pressure and serum creatinine. Results from the 'Clue' Study and the ARIC Study. JAMA 269 (1993) 488-493
22. Pinto-Sietsma S.J., Mulder J., Janssen W.M.T., Hillege H.L., de Zeeuw D., and de Jong P.F. Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med 133 (2000) 585-591
23. Regalado J., Yang S., and Wesson D.E. Cigarette smoking is associated with augmented progression of renal insufficiency in severe essential hypertension. Am J Kidney Dis 35 (2000) 687-694
24. Rosansky S.J., Hoover D.R., King L., and Gibson J. The association of blood pressure levels and change in renal function in hypertensive and nonhypertensive subjects. Arch Intern Med 150 (1990) 2073-2076
25. Walker W.G., Neaton J.D., Cutler J.A., Neuwirth R., and Cohen J.D. Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. JAMA 268 (1992) 3085-3091
26. Jansen M.A., Hart A.A., Korevaar J.C., Dekker F.W., Boeschoten E.W., Krediet R.T., and NECOSAD Study Group. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 62 (2002) 1046-1053
27. Hovind P.J., Rossing P., Tarnow L., Smidt U.M., and Parving H.K. Progression of diabetic nephropathy. Kidney Int 59 (2001) 702-709
28. Manjunath M., Sarnak M., and Levey A. Prediction equations to estimate glomerular filtration rate. An update. Curr Opin Nephrol Hypertens 10 (2001) 785-792
29. National Kidney Foundation. KDOQI Clinical Practice Guidelines. Am J Kidney Dis 39 suppl 1 (2002) S17-S31
30. Chobanian A.V., Bakris G.L., Black H.R., et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 (2003) 1206-1252
31. Joyce A.T., Iacoviello J.M., Nag S., et al. End-stage renal disease associated managed care costs among patients with and without diabetes. Diabetes Care 27 (2004) 2829-2835
32. Smith D.H., Gullion C.M., Nichols G., Keith D.S., and Brown J.B. Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population. J Am Soc Nephrol 15 (2004) 1300-1306